IBDEI0JO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8864,1,4,0)
 ;;=4^Z85.54
 ;;^UTILITY(U,$J,358.3,8864,2)
 ;;=^5063432
 ;;^UTILITY(U,$J,358.3,8865,0)
 ;;=Z85.59^^55^550^18
 ;;^UTILITY(U,$J,358.3,8865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8865,1,3,0)
 ;;=3^Personal history of malignant neoplasm of urinary tract organ
 ;;^UTILITY(U,$J,358.3,8865,1,4,0)
 ;;=4^Z85.59
 ;;^UTILITY(U,$J,358.3,8865,2)
 ;;=^5063433
 ;;^UTILITY(U,$J,358.3,8866,0)
 ;;=Z85.6^^55^550^6
 ;;^UTILITY(U,$J,358.3,8866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8866,1,3,0)
 ;;=3^Personal history of leukemia
 ;;^UTILITY(U,$J,358.3,8866,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,8866,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,8867,0)
 ;;=Z85.79^^55^550^19
 ;;^UTILITY(U,$J,358.3,8867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8867,1,3,0)
 ;;=3^Personal history of malignant neoplasm of lymphoid,hematpoetc & rel tiss
 ;;^UTILITY(U,$J,358.3,8867,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,8867,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,8868,0)
 ;;=Z85.71^^55^550^2
 ;;^UTILITY(U,$J,358.3,8868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8868,1,3,0)
 ;;=3^Personal history of Hodgkin lymphoma
 ;;^UTILITY(U,$J,358.3,8868,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,8868,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,8869,0)
 ;;=Z85.830^^55^550^20
 ;;^UTILITY(U,$J,358.3,8869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8869,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,8869,1,4,0)
 ;;=4^Z85.830
 ;;^UTILITY(U,$J,358.3,8869,2)
 ;;=^5063444
 ;;^UTILITY(U,$J,358.3,8870,0)
 ;;=Z85.828^^55^550^21
 ;;^UTILITY(U,$J,358.3,8870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8870,1,3,0)
 ;;=3^Personal history of malignant neoplasm of skin NEC
 ;;^UTILITY(U,$J,358.3,8870,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,8870,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,8871,0)
 ;;=Z85.841^^55^550^22
 ;;^UTILITY(U,$J,358.3,8871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8871,1,3,0)
 ;;=3^Personal history of malignant neoplasm of brain
 ;;^UTILITY(U,$J,358.3,8871,1,4,0)
 ;;=4^Z85.841
 ;;^UTILITY(U,$J,358.3,8871,2)
 ;;=^5063447
 ;;^UTILITY(U,$J,358.3,8872,0)
 ;;=Z85.848^^55^550^23
 ;;^UTILITY(U,$J,358.3,8872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8872,1,3,0)
 ;;=3^Personal history of malignant neoplasm of prt nervous tissue
 ;;^UTILITY(U,$J,358.3,8872,1,4,0)
 ;;=4^Z85.848
 ;;^UTILITY(U,$J,358.3,8872,2)
 ;;=^5063448
 ;;^UTILITY(U,$J,358.3,8873,0)
 ;;=Z85.850^^55^550^24
 ;;^UTILITY(U,$J,358.3,8873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8873,1,3,0)
 ;;=3^Personal history of malignant neoplasm of thyroid
 ;;^UTILITY(U,$J,358.3,8873,1,4,0)
 ;;=4^Z85.850
 ;;^UTILITY(U,$J,358.3,8873,2)
 ;;=^5063449
 ;;^UTILITY(U,$J,358.3,8874,0)
 ;;=Z85.858^^55^550^25
 ;;^UTILITY(U,$J,358.3,8874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8874,1,3,0)
 ;;=3^Personal history of malignant neoplasm of endocrine glands
 ;;^UTILITY(U,$J,358.3,8874,1,4,0)
 ;;=4^Z85.858
 ;;^UTILITY(U,$J,358.3,8874,2)
 ;;=^5063450
 ;;^UTILITY(U,$J,358.3,8875,0)
 ;;=Z86.61^^55^550^5
 ;;^UTILITY(U,$J,358.3,8875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8875,1,3,0)
 ;;=3^Personal history of infections of the central nervous system
 ;;^UTILITY(U,$J,358.3,8875,1,4,0)
 ;;=4^Z86.61
 ;;^UTILITY(U,$J,358.3,8875,2)
 ;;=^5063472
 ;;^UTILITY(U,$J,358.3,8876,0)
 ;;=Z87.09^^55^550^4
 ;;^UTILITY(U,$J,358.3,8876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8876,1,3,0)
 ;;=3^Personal history of diseases of the respiratory system NEC
 ;;^UTILITY(U,$J,358.3,8876,1,4,0)
 ;;=4^Z87.09
 ;;^UTILITY(U,$J,358.3,8876,2)
 ;;=^5063481
